HEOR Staff Writer

Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Rare Medications Coverage in the Netherlands: Price Reductions Required
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
FDA Approved Eye Drops: Lenz Therapeutics Launches VIZZ for Presbyopia Treatment